What’s 340B? An economist’s view of the recent wave of 340B litigation
But this change has led to complex relationships among pharmaceutical manufacturers, hospitals, pharmacies, and third-party administrators, increasing...
This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.
Empirical and theoretical approaches pioneered by CRA economists have been accepted as standard practice by competition economists and enforcers worldwide.
We tailor our analyses to fit the facts and economics of each case, bringing a unique combination of creativity and rigor to each matter. CRA economists have also testified in litigated competition cases, or met with and provided submissions to antitrust enforcement agencies. In our work, and in discussions with clients, we distill complex competition issues and economic analyses into concepts and arguments that are understandable to non-economists.
Our expertise in antitrust economics, econometrics, mergers, acquisitions, divestitures, and related matters has made us the firm of choice for clients and competition authorities around the globe. Our globally based antitrust economists have the knowledge, jurisdiction-specific expertise, and geographic presence required to efficiently support clients around the world.
But this change has led to complex relationships among pharmaceutical manufacturers, hospitals, pharmacies, and third-party administrators, increasing...
The issue is especially timely given provisions in the EU’s Digital Markets Act (DMA) designed to expand access to data held by large digital platforms. The...
Liz Bailey is the principal lecturer during multiple sessions during the event designed for mid-level or senior antitrust practitioners looking for more than...
CRA is a proud sponsor of the interactive two-day conference bringing together practitioners from across Europe and further afield, including private practice...
CRA is a proud sponsor of the event. Josh Sherman is a panelist during the session titled “Global antitrust trends reshaping the life sciences market”...
CRA is a proud sponsor of the conference focusing on the theme of “Competition and Foreign Investment Law for a Resilient Canada.” At a pivotal moment for...
